Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01651 |
| Species: | Homo sapiens |
| Position : | chr15:56000000-58000000 |
| Year: | 2021 |
| Title: | Epigenomic landscape and 3D genome structure in pediatric high-grade glioma |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | diffuse intrinsic pontine glioma |
| PMID: | 34078608 |
| MONDO: | MONDO:0006049 |
| Tissue: | Pons |
| Tissue Ontology ID: | UBERON:0000988 |
| Cell Source: | Human diffuse intrinsic pontine glioma cell |
| CVCL ID: | |
| Cell Type: | diffuse intrinsic pontine glioma cell |
| Cell Ontology ID: | CL:0000127 |
| Experiment Type: | Chromatin interaction assay, Enhancer activity assay, Copy number variation analysis |
| High Throughput Method: | Hi-C, ChIP-seq, RNA-seq |
| Low Throughput Method: | RT-RT-qPCR |
| Target gene : | TCF12 |
| TF name : | TCF12 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| TCF12 | CDO in myogenesis | reactome | 29 |
| TCF12 | ID | netpath | 38 |